troubleshootTroubleshooting Guide

Semaglutide Plateau

The scale stopped moving. Your appetite still feels different, but the number isn't budging. Plateaus on semaglutide are real, expected, and almost never the end of your progress.

If you have been losing weight steadily on semaglutide and the scale has flattened out for a few weeks, you are not failing the medication. You are running into one of the most predictable patterns in GLP-1 therapy. Almost every long-term trial shows the same curve: a rapid early drop, a slower middle phase, and a plateau where the body settles at a new weight.

That plateau can feel jarring after months of momentum. It can also feel like the medication has stopped working, even though appetite signals, food noise, and portion sizes may still be different than before treatment. The good news is that most plateaus respond to small, specific changes — dose review, protein, sleep, strength training, and an honest look at hidden calories.

This guide walks through what the clinical trials actually show, why plateaus happen biologically, and what you can do this week before scheduling a longer conversation with your provider.

Is this normal?

Yes — and the trial data backs this up. In the STEP 1 trial of semaglutide 2.4 mg, participants lost a mean of −14.9% of body weight by week 68, but the weight-loss curve was not linear. The steepest drop happened in the first several months, then the curve gradually flattened as people approached their new set point. The same pattern shows up in real-world clinics: rapid early loss, then a slower phase, then a plateau.

Plateaus often arrive somewhere between month 4 and month 12, depending on starting weight, dose, and lifestyle. A two to four week stall on the scale is not a plateau in the clinical sense — it is normal week-to-week variation. A true plateau is usually defined as eight or more weeks without meaningful change while you are still on a stable dose and following your plan.

The biology behind it is straightforward. As body weight drops, daily energy needs drop too. Metabolic adaptation also lowers your resting metabolic rate slightly more than weight loss alone would predict. The appetite-suppressing effects of semaglutide remain, but the calorie deficit that drove early loss narrows over time.

Why this happens

Common causes

vaccines

Dose has not been titrated up

Many people plateau because they are still on a maintenance dose below the full 2.4 mg. A planned dose increase, when tolerated, often resumes weight loss.

restaurant

Calories crept back up

Appetite suppression fades slightly over months. Bites, sips, tastes, and liquid calories add up. A short food log usually reveals the gap.

fitness_center

Muscle loss lowered metabolism

Rapid weight loss without strength training shifts body composition. Less muscle means a lower resting burn, which makes plateaus more likely.

bedtime

Sleep and stress

Short sleep raises hunger hormones and cortisol, both of which work against a GLP-1. Even on medication, chronically poor sleep stalls progress.

local_bar

Alcohol returned

Alcohol is calorie-dense, disinhibits eating, and disrupts sleep. A weekly drink or two rarely matters; nightly drinks usually do.

monitor_weight

New set point reached

Sometimes the body has genuinely settled at a new, healthier weight. That is a clinical success, even if it is not the goal weight.

What you can do this week

Start with the highest-leverage changes. The most common single fix is a dose review. If you are not on the full 2.4 mg maintenance dose and you have been on your current dose for at least four weeks without side effects, ask your provider whether the next titration step is appropriate. Do not change your dose on your own.

Audit protein next. Aim for roughly 0.7 to 1.0 grams of protein per pound of goal body weight, spread across the day. Protein protects lean mass, increases satiety, and has the highest thermic effect of any macronutrient. Most people who plateau are eating less food overall but a much smaller share of protein than they realize.

Add or increase resistance training. Two to three short sessions per week — even bodyweight squats, push-ups, rows, and carries — preserve the muscle that keeps your metabolism higher. Walking is excellent for adherence and mood, but it does not protect muscle the way lifting does.

Tighten the boring stuff. Seven to nine hours of sleep, water before meals, a two-week alcohol pause, and an honest re-log of everything you eat and drink for five days will almost always either restart loss or reveal exactly why it stopped.

When to talk to your provider

Common Concerns

How long should I wait before talking to my doctor about a plateau?expand_more

If the scale has not moved for eight weeks despite consistent dosing, food intake, and activity, that is a reasonable point to bring it up. Sooner if you have other symptoms, are gaining weight, or feel the medication's appetite effect has fully disappeared.

Will increasing my dose help?expand_more

Often, yes — if you are not already at the maintenance dose of 2.4 mg. Higher doses produced more weight loss in trials. That said, more medication is not always better, and your provider will weigh side effects, comorbidities, and how close you are to your goal.

Should I stop the medication?expand_more

Usually not. In the STEP 1 extension, people who stopped semaglutide regained about two thirds of their lost weight within a year. A plateau is not a reason to discontinue. It is a reason to revisit dose, lifestyle, and goals with your provider.

Could switching to tirzepatide help?expand_more

In head-to-head and indirect comparisons, tirzepatide produces somewhat greater weight loss on average. Switching is a real option for some people who have plateaued well short of their goal, but it is a clinical decision that depends on cost, insurance, and tolerability.

Keep exploring

Browse all GLP-1 guides or read about dosing schedules.